Price Reductions

Click the links on this page to read or download Price Reductions

May 2014

GMS Reimbursed Prices of Generics 1 May 2014 (size 139 KB)
High Tech Reimbursed Prices of Generics 1 May 2014 (16.9KB)
The Generic Price Reductions effective 1st May 2014 have been calculated on the basis that from 1st May 2014 the HSE will only reimburse generic products which have been priced at 40% or less of the pre patent expiry prices of the equivalent branded original products.

Oct 2013

Esomeprazole and Rosuvastatin revised prices effective 1 Oct 2013.pdf (size 22 KB)
The attached document details revised prices for Esomeprazole and Rosuvastatin containing products which will be implemented by the Primary Care Reimbursement Service from 1 October 2013. Please note these are not reference prices, they are product specific reimbursement prices.

Sept 2013

Atorvastatin Revised Prices effective 1 September 2013.pdf (size 52.4 KB)
The attached document details revised prices for Atorvastatin containing products which will be implemented by the Primary Care Reimbursement Service from 1 September 2013. Please note these are not reference prices, they are product specific reimbursement prices.

Jan 2013

Corrections and Additions to the Price Reductions List effective 1 Jan 2013.pdf (size 11 KB)
This is a list of price reductions for implementation on the 1st Jan 2013. Additions and corrections will be published on the HSE Corporate Pharmaceutical Unit section of the HSE website.

Nov 2012

The Generic Price Reductions effective 1st Nov 2012 have been calculated on the basis that from 1st November the HSE will only reimburse generic products which have been priced at 50% or less of thepre patent expiry prices of the equivalent branded original products. In the event that an originator medicine is priced at less than 50% of itspre patent expiry price the HSE will require a generic price to be priced below the originator price.